Navigo Proteins leverages its unique protein engineering expertise in Precision Capturing® for optimized biopharmaceutical downstream processing. We engineer highly stable scaffold protein-based custom affinity chromatography solutions for commercial manufacturing.
Navigo Proteins employs its unique protein engineering expertise in Precision Targeting to create next-generation Affilin®-based biotherapeutics. We design and develop target specific Affilin® ligands and fuse them to effector modules.
Precision X affinity ligands are small (~6.5 kDa), selective and stable proteins based on our proprietary artificial Protein A scaffold. They no longer have to bind to antibodies’ Fc parts, but instead we engineer new, specific binding characteristics …
The long-standing, successful use of radio-theranostics in imaging and therapy is based on targeting radiolabeled molecules to tumors or other diseased tissues. Over 10,000 hospitals worldwide use radioisotopes for …
Scaffold Protein-based Affinity Ligands for Custom Affinity Chromatography Solutions and Next-Generation Biopharmaceutical Drugs.